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Background. Cardiac tamponade (CT) represents a life-threatening condition, and the optimal method of draining accumulated
pericardial ﬂuid remains controversial. We have reviewed 100 patients with CT at our institution over a ﬁve-year period
and compared the results of echo-guided pericardiocentesis, primary surgical treatment, and surgical treatment following
pericardiocentesis with regard to functional outcomes. Methods. The study group consisted of 100 patients with CT attending
Yuzuncu Yil University from January 2005 to January 2010 who underwent one of the 3 treatment options (echo-guided
pericardiocentesis, primary surgical treatment, and surgical treatment following pericardiocentesis). CT was deﬁned by clinical
and echocardiographic criteria. Data on medical history, characteristics of the pericardial ﬂuid, treatment strategy, and follow-
up data were collected. Results. Echo-guided pericardiocentesis was performed in 38 (38%) patients (Group A), primary surgical
treatment was preformed in 36 (36%) patients (Group B), and surgical treatment following pericardiocentesis was performed in
26(26%)patients(GroupC).Idiopathicandmalignantdiseaseswereprimarycauseoftamponade(28%and28%,resp.),followed
bytuberculosis(14%).Total complication rates,30-daymortality,and total mortalityrateswere highest inGroup C.Recurrenceof
tamponade before 90 days was highest in Group A. Conclusions. According to our results, minimal invasive procedure echo-guided
pericardiocentesis should be the ﬁrst choice because of lower complication and mortality rates especially in idiopathic cases and in
patients with hemodynamic instability. Surgical approach might be performed for traumatic cases, purulent, recurrent, or malign
eﬀusions with higher complication and mortality rates.
1.Introduction
Cardiactamponade(CT)isaclinicalsyndromecharacterized
by hemodynamic abnormalities resulting from an increase
in pericardial pressure due to accumulation of contents
such as serous ﬂuid, blood, and pus [1]. Idiopathic or viral
pericarditis, iatrogenic injury (invasive procedure-related,
post-CABG), trauma, malignancy, uremia, collagen vascu-
lar disease, tuberculosis, postmyocardial infarction, aortic
dissection and bacterial infection may lead to CT [1]. In
1935, Beck described diagnostic triad for CT consisting of
decreasing arterial pressure, increasing venous pressure, and
quiet heart [2]. Increasing intrapericardial pressure leads
to restriction of cardiac ﬁlling, reduction of stroke volume,
and cardiac output [2, 3]. Clinical signs in patient with CT
include hypotension, tachycardia, pulsus paradoxus, raised
jugular venous pressure, muﬄed heart sounds, decreased
electrocardiographic voltage, and enlarged cardiac silhouette
onchestroentgenogram[3].Echocardiographyisconsidered
the primary imaging modality for the evaluation of pericar-
dial eﬀusion because of its high sensitivity and speciﬁcity,
lack of ionizing radiation, and low cost. Computerized
tomography and magnetic resonance imaging are indicated
when ﬁndings at echocardiography are inconclusive [4].
The treatment of CT is based on clinical presen-
tation and may involve pericardial content removal by2 Cardiology Research and Practice
percutaneous pericardiocentesis, balloon pericardiotomy, or
surgical drainage [5]. More recently, echocardiographic-
guided pericardiocentesis has been demonstrated to be a
safe and eﬀective procedure that can be performed at the
bedside [6]. However, if pericardial tissue is required for
diagnosis or in the case of purulent pericarditis or recurrent
eﬀusions, surgical drainage may be the preferred treatment.
Also, immediate surgical approach should be performed
for traumatic hemopericardium [7]. We have reviewed all
patients with cardiac tamponade in our institution over a
ﬁve-year period to determine the causes of cardiac tampon-
ade, clinical aspects, treatment modalities, and long-term
followup.
2.SubjectsandMethods
2.1. Patients. The study was approved by the local ethics
committee in accordance with the Declaration of Helsinki.
The medical records of all patients with cardiac tamponade
of our hospital from January 2005 to January 2010 were
reviewed. Cardiac tamponade was deﬁned by clinical and
echocardiographic criteria [8, 9]. Two-dimensional echocar-
diographic criteria of CT were early diastolic collapse of
the right ventricle, late diastolic collapse of the right or
left atrium, and plethora of the inferior vena cava with
pericardial eﬀusion [10]. Doppler echocardiographic criteria
of CT were major increases of tricuspid E ﬂow and major
decreases of mitral E ﬂow during inspiration [11]. In
all cases, the location and distribution of the pericardial
eﬀusion leading to tamponade were conﬁrmed by two-
dimensional and doppler echocardiography (Vivid 3, GE
Vingmed Ultrasound, Horten, Norway). Victims with CT
due to penetrating trauma were excluded from study.
2.2. Procedures and Techniques. Pericardiocentesis was done
by subxiphoid approach. Percutaneous drainage was ini-
tiated with an 8cm, 18-gauge angiocatheter. When the
pericardial sac was entered, the sheath was advanced and
the needle withdrawn. A guide wire was then advanced
through the angiocatheter, followed by a dilator and a
60cm, 6F pigtail catheter. Pericardial ﬂuid was fully drained
and submitted for culture and cytological analysis. The
sheath position was readily conﬁrmed by injecting a small
amount of agitated saline. The eﬀusion was initially drained
completely,asassessedbyrepeatedechocardiography.Subse-
quently,intermittentaspirationswereperformedasclinically
indicated, usually every 4 to 6 hours, until the ﬂuid
return over a 24-hour period had decreased to less than
25mL. Followup with two-dimensional echocardiographic
assessment was satisfactory. The aspiration was not drained
more than 1000mL at initial time due to acute right
ventricular dilatation and hypotensive shock [5, 11]. Major
complications included any undesirable events occurring
as a result of pericardiocentesis that required intervention
such as need for emergency surgery, ventricular arrhythmia,
and perforation of cardiac chamber, hemothorax, and pneu-
mothorax. Minor complications were those that required no
management, except appropriate monitoring and followup
[11]. Recurrence was deﬁned as reaccumulation of ﬂuid
requiring intervention and was further categorized as to
whether it occurred within or beyond 90 days of the initial
pericardiocentesis [12, 13].
2.2.1. Surgical Drainage Procedures. Subxiphoid surgical
drainage technique was done by subxiphoid approach.
A 5–10cm skin incision was made from the lower end
of the sternum and extended caudally approximately 5cm.
The upper linea alba was divided at the midline and xiphoid
sternum was resected. A portion of the anterior pericardium
was excised. The pericardial eﬀusion was aspirated and ﬂuid
sample was sent for histological examination. A 28 F caliber
chest tube was inserted posteriorly to the pericardium and
left until the following 3-4 days.
Pericardioperitoneal window technique was done by local
anesthesia.
The diaphragm and inferior pericardium were incised
to create a pericardioperitoneal window. The edges of
windows were stitched with interlocking sutures using 4-
0 polypropylene to prevent closure. Fluid and pericardium
sample was sent for histological examination. A drainage
tube was inserted into pericardial space and left until the
following day.
Left anterior minthoracotomy technique was done by
general anesthesia. Patients were yielded at left lateral
decubitis position. Chest is opened between 4th and 5th
intercostal spaces. A 4-5cm portion of the left pericardium
was excised. Fluid and pericardium sample was sent for
histological examination. A drainage tube was inserted into
pleural space and left until the following 3-4 days.
2.3. Outcomes. Outcomes of interest included procedural
success, major and minor complication rates, eﬀusion recur-
rence rates, and survival. Pericardiocentesis was considered
successful if the pericardial ﬂuid was drained with relief of
tamponade. Major complication is considered as an unde-
sirable event occurring as a result of pericardiocentesis that
required intervention such as need for emergency surgery,
cardiogenic shock, ventricular arrhythmia, perforation of
cardiac chamber (iatrogenic cardiac injury), hemothorax,
and pneumothorax. Minor complication is considered an
event that required no management except appropriate
monitoring and followup (hypotension, low cardiac out-put,
tachycardia, etc.).
2.4. Statistical Analyses. All statistical analyses were con-
ducted using SPSS system version 10.0 (SPSS, Inc., Chicago,
Ill., USA). Descriptive statistics are presented as means ±
standard deviation (SD) or by frequency percentages. Uni-
variate comparison of categoric variables was done using
Z test analysis. Multivariate risk analysis identiﬁed factors
responsible for increased risk of eﬀusion recurrence. Statis-
tical diﬀerences were considered signiﬁcant if the probability
w a s0 . 0 5o rl e s s .Cardiology Research and Practice 3
3. Results
This study group consisted of 100 consecutive patients,
51 (51%) female and 49 (49%) male patients, ranging
in age from 10 to 79 years with a mean age of 46.3 ±
21.9 years. In our series 18 patients were <18 years, 57
patients were 18–60 years, and 25 patients were >60 years
old. There were diﬀerences between groups in age and sex
(P ≤ 0.01). Initial complaints of patients were dyspnea
89%, palpitation 61%, pretibial edema 48%, tachycardia
(>100beats/min) 82%, QRS alternation 29%, low QRS
voltage 81%. There were diﬀerences between groups in
initial complaints of patients (P ≤ 0.01). Hemodynamic
status of the patients were echocardiographic tamponade
(3cm ﬂuid accumulation within pericardial sac conﬁrmed
by echocardiography) 48%, clinical tamponade 44%, and
hemodynamic collapse 8%. There were diﬀerences between
Group C to Group A and B in hemodynamic status of the
patients (P ≤ 0.01). There were no diﬀerences between
Group A and B in hemodynamic status of the patients.
Characteristics of patients were summarized in Table 1.
Eﬀusion characteristics of patients were circumferential
distribution 78%, and loculated distribution 22%. There
were diﬀerences between Group B to Group A and C
in distribution of eﬀusion of the patients (P ≤ 0.01).
There were no diﬀerences between Group A and C in
distribution of eﬀusion of the patients. Size of the eﬀusions
were large (echocardiographically >2cmeﬀusion) 76% and
small (echocardiographically <2cm eﬀusion) 24%. There
were diﬀerences between groups in size of eﬀusion of the
patients (P ≤ 0.01). Color of the eﬀusions was; bloody
47%, serosanguineous 18%, and serous 35%. There were
diﬀerences between groups in colors of the eﬀusions of the
patients (P ≤ 0.01). Eﬀusion characteristics of patients were
summarized in Table 2.
Etiology of all patients was malignancy 28% (13 patients
had lung malignancy, 3 patients breast, 4 patients thy-
roid papillary malignancy, 2 patients esophagus, 4 patients
mesothelioma, and 2 patients had renal cell malignancy)
postoperative 2%, cardiac perforation from invasive pro-
cedure 6%, infection 4%, connective tissue disease 2%,
ischemic heart disease related 2%, idiopathic 28%, hypothy-
roidism6%,acuterheumatismalfever4%,tuberculosis14%,
and warfarin overdose 4%. Idiopathic (28%), malign (28%)
and tuberculous (14%) pericardial eﬀusions were more
frequently seen. There were diﬀerences between groups in
etiology of pericardial tamponade (P ≤ 0.01). Etiology of
pericardial tamponade of 3 study groups were summarized
in Table 3.
There were diﬀerences between Group B to Group A
and C in major complications (P ≤ 0.01). There were no
diﬀerences between Group A and C in major complications.
TherewerediﬀerencesbetweenGroupBtoGroupAandCin
minor complications (P ≤ 0.01). There were no diﬀerences
between Group A and C in minor complications.
When the recurrences reviewed, there were 16 (16%)
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A (26%), 3 cases in Group B (8%), and 3 cases in Group C
(11%) were seen. There were diﬀerences between groups in
recurrences before 90 days (P ≤ 0.01). When the recurrences
were reviewed according to etiologic causes; 6 of the patients
were from tuberculosis (16%), 3 from malignancy (8%),
and 1 patient diagnosed idiopathic (2%) in Group A. No
patientwasrecurredfromtuberculosis(0%)andmalignancy
(0%), 3 patients diagnosed idiopathic (8%) in Group B.
Similarly, no patient was recurred from tuberculosis (0%),
and malignancy (0%) 3 patients recurred with the diagnosis
of idiopathic (11%) in Group C. When the 30-day mortality
rates were reviewed, there were 5 (5%) patients seen. There
werediﬀerencesbetweengroupsinthe30-daymortalityrates
(P ≤ 0.01). Group A: 5% (2/38), Group B: 3% (1/36), and
Group C: 7% (2/26). Exitus was seen in 12 patients. There
were diﬀerences between groups in exitus rates (P ≤ 0.01).
Group A: 13% (5/38) patients, Group B: 8% (3/36) patients,
and Group C: 15% (4/26) patients. Complete followup was
achieved in 93% (93) patients. The mean followup time for
the population was 3.5 ± 0.4y e a r s .Complications, recur-
rences, and followup of patients were summarized in Table 4.
4. Discussion
Cardiac tamponade is a treatable cause of cardiogenic shock
that can be rapidly fatal if unrecognized [13]. Patients
with impending or early tamponade are usually anxious
and may complain of dispnea and chest pain [13]. In our
study, the predominant symptom of patients was dyspnea
(89%) and the main ﬁnding was tachycardia (82%). These
ﬁndings were consistent with other series [6, 14]. Cardiac
tamponade have long been associated with low voltage of
the 12-lead electrocardiogram (ECG), and the diagnostic
accuracy, sensitivity, and speciﬁcity of this ECG ﬁnding
have previously been reported [15]. Diﬀerent mechanisms
have been proposed to explain low QRS voltage associated
with pericardial eﬀusion and CT. These mechanisms include
mechanic-electrical alterations of the myocardium which
is generally seen in chronic heart failure, distance of the
heart from body surface electrodes and reduction of cardiac
size and volume [16]. Bruch and coworkers reviewed 43
patients with signiﬁcant pericardial eﬀusion, ﬁnding 61%
of cardiac tamponade. Main ECG ﬁnding of this report
was that low QRS voltage was present in the majority of
subjects with CT [17]. 81% of patients had low QRS voltage
in our study population. Hemodynamic statuses of our
patients were echocardiographic tamponade 48%, clinical
tamponade 44%, and hemodynamic collapse 8%. In a Mayo
clinic series that included 1127 patient echocardiographic
tamponade rate was 49.8%, clinical tamponade rate was
44.2%, and hemodynamic collapse rate was 9.8% [6].
Allen and colleagues reported on a series of 117 patients
with CT; etiologic causes were 64% malignancy (most
often lung and breast), and benign disease 36% (most
often idiopathic and uremic) [18]. In a Mayo clinic series
etiologic causes of CT were malignancy (33%) and cardiac
perforation from invasive procedure (10.3%) [6]. In our
study, idiopathic (28%), malignant (28%), and tuberculous
(14%) pericardial eﬀusions were more frequently seen. The
incidence of metastatic disease to the myocardium and/or4 Cardiology Research and Practice
Table 1: Characteristics of patients.
Group Group A (n : 38) Group B (n : 36) Group C (n : 26) Mean
Sex Male (n : 17) Female (n : 21) Male (n : 16) Female (n : 20) Male (n : 16) Female (n : 10) n : 100
Age (year) 41.3 ±26.53 5 .8 ±21.64 3 .3 ±21.54 7 .9 ±22.85 4 .3 ± 32.35 5 .7 ±31.94 6 .3 ±21.9
Patients <1 8 y e a r s 342342 1 8
Patients 18–60 years 9 11 9 13 8 7 57
Patients >6 0 y e a r s 565441 2 5
Initial complaint of patients
Dispnoea 16 17 14 18 15 9 89
Palpitation 4 11 12 14 14 6 61
Pretibial edema 3 7 12 14 6 6 48
Tachycardia (100beats/min) 14 18 14 16 12 8 82
QRS alternation 7 6 4 5 4 3 29
L o w Q R S v o l t a g e 1 41 81 21 61 3 88 1
Hemodynamic status
Echocardiographic tamponade 8 10 6 11 8 5 48
C l i n i c a l t a m p o n a d e 988874 4 4
H e m o d y n a m i c c o l l a p s e 122111 8
Table 2: Eﬀusion characteristics of patients.
Group Group A (n : 38) Group B (n : 36) Group C (n : 26) Mean
Sex Male (n : 18) Female (n : 20) Male (n : 16) Female (n : 20) Male (n : 16) Female (n : 10) n : 100
Distribution of eﬀusion
C i r c u m f e r e n t i a l 1 41 51 31 61 3 7 7 8
L o c u l a t e d 453433 2 2
Size of eﬀusion
Large (eco >2cm)eﬀu s i o n 1 31 41 21 51 4 8 7 6
Small (eco <2cm)eﬀu s i o n 564522 2 4
Color of eﬀusions
Bloody 9 10 10 6 7 5 47
Serosanguineous 242523 1 8
S e r o u s 676745 3 5
eco: echocardiography.
Table 3: Etiology of cardiac tamponade.
Group Group A (n : 38) Group B (n : 36) Group C (n : 26) Mean
A g e g r o u p s abCabCabc n : 100
M a l i g n a n c y 003195064 2 8
P o s t o p e r a t i v e 000010010 2
Cardiac perforation from invasive
procedure 000240000 6
I n f e c t i o n 000121000 4
C o n n e c t i v e t i s s u e d i s e a s e 000110000 2
I s c h e m i c h e a r t d i s e a s e r e l a t e d 000011000 2
Idiopathic 2 10 5 1 6 1 2 6 3 28
Hypotroidiea 3 3 0 2 2 0 0 0 0 6
A c u t e r h e u m a t i s m a l f e w e r 110100100 4
T u b e r c u l o s i s 151141204 1 4
W a r f a r i n o v e r d o s e 021030010 4
(a) patients <18 years; (b) patients 18–60 years; (c) patients >60 years.Cardiology Research and Practice 5
Table 4: Complications, recurrences, and followup of patients.
Group Group A (n : 38) Group B (n : 36) Group C (n : 26) Mean
Sex Male (n : 18) Female (n : 20) Male (n : 16) Female (n : 20) Male (n : 16) Female (n : 10) n : 100
Total complication
M a j o r 110111 5
M i n o r 111023 8
Recurrence ≤9 0 d a y 641221 1 6
3 0 d a y m o r t a l i t y r a t e 11012o 7
E x i t u s 231231 1 2
Complete followup 17 19 16 18 15 9 93
Mean follow-up (year) 3.2 ±0.53 .6 ±0.43 .5 ±0.53 .5 ±0.4
Table 5: Etiology of cardiac tamponade according to groups.
Group M P C I Con Isc Id H A T W
A( n : 38) 3 (7%) 0 0 0 0 0 17 (44%) 6 (15%) 2 (7%) 6 (15%) 3 (7%)
B( n : 36) 15 (41%) 1 (2%) 6 (16%) 4 (11%) 2 (5%) 2 (5%) 3 (8%) 0 1 (2%) 1 (2%) 1 (2%)
C( n : 26) 10 (38%) 1 (3%) 0 0 0 0 8 (30%) 0 1 (3%) 6 (23%) 0
P ≤0.01 ≤0.01 ≤0.01 ≤0.01 ≤0.01 ≤0.01 ≤0.01 ≤0.01 ≤0.01 ≤0.01 ≤0.01
(M:malignancy,P:postoperative,C:cardiacperforationfrominvasiveprocedure,I:infection,Con:connecticetissuediseas,Isc:ischemicheartdiseaserelated,
Id: idiopathic, H: hypotroidiea, A: acute rheomatismal fewer, T: tuberculosis, W: warfarin overdose).
pericardium ranges from less than 1 percent up to 18 percent
of all cancer [19]. Lung and breast cancer which are the
most common malignancies comprise nearly one-half of
all metastatic lesions to the heart. Melanoma, leukemia,
and lymphoma which occur less commonly, involve the
pericardium in approximately 50 percent of patients [20–
22]. In our series, most common malignancy was lung
cancer. Tuberculosis is believed to be one of the main causes
of pericarditis in developing countries [23]. Tuberculosis
is diagnosed in 14% of patients in our series (Table 5).
When CT results from hemorrhage into the pericardium,
there can be rapid circulatory collapse because not only
does intrapericardial pressure rapidly rise but intravascular
volume falls, preventing a compensatory increase in venous
pressure [5]. Therefore, during any invasive cardiologic
intervention, operating room should be prepared due to
possible risk of cardiac rupture [24]. In our series, cardiac
tamponade and shock developed in 6 patients (6%) during
invasive cardiologic procedure. They were operated on
successfully without delay. Critical patients who presented
with cardiac tamponade and pericardial eﬀusion must be
evacuated quickly. But which method to use for treatment
is a controversial issue today. First implemented in 1841
pericardiocentesis with a needle, ﬁxing the symptoms of
patients but the permanent treatment cannot be provided
[25]. This method in patients with tamponades is more
applicable in intensive care and a less invasive method.
However, mortality, complication, and recurrence rates are
high. In a study by Kopecky and his colleagues with 42
patients there were no mortality, however, complication rate
was 2.4% and recurrence rate was 24% [26]. In another
study of Celermajer and his colleagues with 36 patients,
mortality,complication,andrecurrencerateswere3%,5.6%,
19.4%, respectively [27]. Successful pericardiocentesis with
a needle of tamponade in the study of Markiewicz 83% of
patients had recurred [28]. Echo-guided pericardiocentesis
t e c h n i q u ew a sﬁ r s tr e p o r t e da ss a f ea n de ﬀective by Mayo
Clinic Group in pilot studies in the early 1980s [6]. In
Mayo clinic follow-up series, echo-guided pericardiocentesis
was conﬁrmed to be safe and eﬀective for treatment of
clinically signiﬁcant pericardial eﬀusions. The procedural
success rate was 97%. The overall total complication rate
of 4.7% [6]. Our results are in accordance with the above-
mentioned data (success rate 97%, total complication rate
10%). Echo-guided pericardiocentesis is well tolerated by
patients, and can be performed quickly even in unstable
patients. Symptoms associated with the pericardial eﬀusion
are relieved rapidly [6]. Pericardial catheters for extended
drainage may remain in place without compromising patient
mobility. The necessary equipment is widely available and
portable, and the technique is adaptable to a broad spectrum
of circumstances. Excellent results of echo-guided peri-
cardiocentesis associated with emergency pericardiocentesis
performedincriticallyunstablepatientshavebeenpublished
[6, 28, 29]. For all these reasons, echo-guided pericardio-
centesis appears to be a more practical and useful procedure
than other reported percutaneous techniques [30]. Drainage
of pericardial eﬀusion by the subxiphoid region which was
ﬁrstly described by Larrey in 1829 is the preferred method
by many surgeons [31]. Treatment of patients with cardiac
tamponades by subxifoid pericardial window method is
simple and reliable [12, 14, 18, 32]. Even though the method
has higher cost of implementation and is more invasive
than percutaneous catheter drainage, it has more advantages
to other techniques such as implementation chance under
local anesthesia, visibility of tamponade directly from the
pericardial cavity, and the opportunity of taking pericardial
biopsy to clarify the etiology. Mortality, complications, and6 Cardiology Research and Practice
Table 6: Complications, recurrences, and followup periods of patients according to groups.
Group A (n : 38) Group B (n : 36) Group C (n : 26) P
Complication 4 (10%) 2 (5%) 4 (15%) ≤0.01
Major 2 (5%) 1 (2.5%) 2 (7%) ≤0.01
Minor 2 (5%) 1 (2.5%) 2 (7%) ≤0.01
Recurrences and etiology 10 (26%) 3 (8%) 3 (11%) ≤0.01
Tuberculosis 6 (16%) 0 0 ≤0.01
Malignancy 3 (8%) 0 0 ≤0.01
˙ Idiopathic 1 (2%) 3 (8%) 3 (11%) ≤0.01
30-day mortality rate 2 (5%) 1 (3%) 2 (8%) ≤0.01
Exitus 5 (13%) 3 (8%) 4 (15%) ≤0.01
Coagulopathy 1 (2.6%) 0 1 (4%) ≤0.01
Ischemic heart disease and cardiac failure 1 (2.6%) 0 0 ≤0.01
Tuberculosis 1 (2.6%) 0 0 ≤0.01
Malignancy 2 (5% ) 3 (8%) 3 (11%) ≤0.01
Complete followup 36 (94%) 34 (94%) 24 (92%) NS
recurrence rates of patients with subxiphoid pericardial
windowarelow[12,14,18,32].Surgicaldrainageprocedures
(partial or complete pericardiectomy, pericardial window)
were popular in earlier years because of their association
with low eﬀusion recurrence rates [33]. However, the need
for a general anesthesia in many of these procedures,
with the attendant perioperative morbidity and mortality is
undesirable. In a study of patients who underwent surgery
for treatment of malignant eﬀusion, a 30-day mortality rate
of 19.4% was reported [33]. In another series involving 41
patients who underwent subxiphoid pericardiostomy, the
30-day mortality rate was 19.5% [34]. In our series 30
day mortality rates were as follows Group A: 5% (2/38),
Group B: 3% (1/36), and Group C: 7% (2/26). Simple
pericardiocentesis, without extended catheter drainage, has
beenassociated withrecurrenceratesof upto 55% [6,28].In
o u rs e r i e sr e c u r r e n c e sr a t e sb e f o r e9 0d a yr a t e sw e r eh i g h e s t
in Group A. When the recurrences were reviewed according
to etiologic causes, we suggested that surgery should be
performed rather than pericardiocentesis in the diagnosis
of tuberculosis and malignancy. When the 30 day mortality
rates were reviewed, we interpreted that surgery following
pericardiocentesis has highest 30-day mortality rates. When
the complications wer reviewed, we demonstrated that
surgery has lower complication rates than other techniques
by regarding the diagnosis. 12 patients died during followup,
of whom 1 from coagulopathy, 2 from ischemic heart
disease and cardiac failure, 1 from tuberculosis, and 8 from
malignancy (Table 6).
5. Conclusions
The most common causes of CT were idiopathic and
cancer. Echo-guided pericardiocentesis is safe, and the rate
of complications has remained stable despite the fact that a
g r e a t e rn u m b e ro fp r o c e d u r e sh a v eb e e np e r f o r m e do na n
emergency basis. Surgery might be preferred in purulent,
recurrent, and/or malign eﬀusions and if pericardial biopsy
is required for diagnosis. Also immediate surgical approach
shouldbeperformedfortraumatichemopericardium,other-
wise, less invasive procedure echo-guided pericardiocentesis
might be the ﬁrst choice especially in idiopathic cases and in
patients with hemodynamic instability.
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